Manejo de la axila en el cáncer de mama: menos es más, más es menos o todo lo contrario

Montero Luis, Ángel; Algara López, Manuel.
Rev. senol. patol. mamar. (Ed. impr.) ; 29(1): 1-3, ene.-mar. 2016.
Artículo en Español | IBECS (España) | ID: ibc-149864

Documentos relacionados

  1. Sentinel lymph node biopsy for breast cancer during pregnancy: A comprehensive update.
  2. Healing activities construct the objects of therapy: Medicine's way of seeking truth, organizing forms of reality, regulating patients' bodies, illness and culture?
  3. A systematic review and meta-analysis of diagnostic performance of fluorescein-guided sentinel lymph node biopsy in early breast cancer.
  4. Is sentinel lymph node biopsy without frozen section in early stage breast cancer sufficient in accordance with ACOSOG-Z0011? A retrospective review from King Chulalongkorn Memorial Hospital.
  5. The sensitivity and specificity of methylene blue dye as a single agent in sentinel lymph node biopsy for early breast cancer.
  6. The Oncologic Safety of Sentinel Lymph Node Biopsy in Patients with Node-Positive Breast Cancer with Complete Response to Neoadjuvant Chemotherapy: A Single-Center Experience.
  7. Targeted axillary dissection: worldwide variations in clinical practice.
  8. Sentimag® Technique for Sentinel Lymph Node Biopsy in Breast Cancer Patients: Evaluation of Effectiveness, Feasibility and Challenges.
  9. Use of methylene blue dye for lymphatic basin mapping and sentinel lymph node biopsy in breast cancer patients in Enugu, Nigeria.
  10. Indocyanine green combined with methylene blue versus methylene blue alone for sentinel lymph node biopsy in breast cancer: a retrospective study.